Chemoimmunotherapy in advanced esophageal squamous cell carcinoma: optimizing chemotherapy regimens for immunotherapy combinations

Signal Transduct Target Ther. 2022 Jul 13;7(1):233. doi: 10.1038/s41392-022-01077-w.

Zhichao Liu^{1

2}, Jun Liu^{2

3}, Zhigang Li^{4

5}

¹ Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
² Esophageal Diseases Center, Shanghai Jiao Tong University, Shanghai, China.
³ Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
⁴ Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. zhigang.li@shsmu.edu.cn.
⁵ Esophageal Diseases Center, Shanghai Jiao Tong University, Shanghai, China. zhigang.li@shsmu.edu.cn.

No abstract available

Publication types